Mario Niepel
Ribon Therapeutics (United States)(US)Rockefeller University(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Computational Drug Discovery Methods, Cell Image Analysis Techniques, Bioinformatics and Genomic Networks, HER2/EGFR in Cancer Research
Most-Cited Works
- → Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs(2016)713 cited
- → The nuclear pore complex: bridging nuclear transport and gene regulation(2010)607 cited
- → The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations(2017)436 cited
- → Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data(2009)402 cited
- → L1000CDS2: LINCS L1000 characteristic direction signatures search engine(2016)373 cited
- → Discovery of Potent and Selective Covalent Inhibitors of JNK(2012)354 cited
- → LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures(2014)338 cited
- → ADP‐ribosyltransferases, an update on function and nomenclature(2021)314 cited
- → Classic and contemporary approaches to modeling biochemical reactions(2010)293 cited
- → Non-genetic cell-to-cell variability and the consequences for pharmacology(2009)233 cited